Recruiting
Phase 2

A Phase 2 Study of Vosoritide in Children with Idiopathic Short Stature

Sponsor:

BioMarin Pharmaceutical

Code:

NCT06382155

Conditions

Idiopathic Short Stature

Eligibility Criteria

Sex: All

Age: 3 - 10

Healthy Volunteers: Not accepted

Interventions

Vosoritide Injection

Human Growth Hormone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information